IC
TARA icon

Ikarian Capital’s Protara Therapeutics TARA Stock Holding History

Ikarian Capital’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-350,489
Closed -$1.85M – 216
2024
Q4 		$1.85M Buy
350,489
+194,777
+125% +$629K 0.25% 84
2024
Q3 		$285K Sell
155,712
-25,000
-14% -$51.4K 0.04% 130
2024
Q2 		$376K Sell
180,712
-21,989
-11% -$64.3K 0.07% 99
2024
Q1 		$813K Buy
202,701
+14,037
+7% +$45.3K 0.09% 109
2023
Q4 		$353K Hold
188,664
– – 0.03% 120
2023
Q3 		$315K Hold
188,664
– – 0.04% 116
2023
Q2 		$451K Hold
188,664
– – 0.07% 100
2023
Q1 		$585K Hold
188,664
– – 0.13% 92
2022
Q4 		$506K Hold
188,664
– – 0.12% 56
2022
Q3 		$558K Sell
188,664
-69,189
-27% -$234K 0.11% 80
2022
Q2 		$756K Sell
257,853
-38,573
-13% -$141K 0.14% 89
2022
Q1 		$1.51M Buy
296,426
+17,170
+6% +$90.3K 0.2% 81
2021
Q4 		$1.89M Sell
279,256
-200,739
-42% -$1.38M 0.28% 67
2021
Q3 		$3.32M Sell
479,995
-104,809
-18% -$817K 0.23% 96
2021
Q2 		$5.7M Sell
584,804
-64,738
-10% -$733K 0.46% 59
2021
Q1 		$10.2M Hold
649,542
– – 0.34% 68
2020
Q4 		$15.7M Sell
649,542
-72,901
-10% -$1.57M 0.69% 34
2020
Q3 		$12.2M Buy
722,443
+194,479
+37% +$4.51M 0.88% 29
2020
Q2 		$15.5M Buy
527,964
+77,192
+17% +$2.39M 1.23% 21
2020
Q1 		$10.4M Buy
450,772
+442,363
+5,261% +$12.9M 0.78% 32
2019
Q4 		$138K Buy
+8,409
New +$96.5K 0.02% 99

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Ikarian Capital's TARA Position: Q1 2025 in Review

Ikarian Capital sold out of Protara Therapeutics (TARA) in Q1 2025, closing a stake of 350,489 shares — an estimated $1.85M sold.

Ikarian Capital first reported a position in TARA in Q4 2019 and held it in 21 quarters. The position peaked at $15.7M in Q4 2020. 59 funds tracked by Wall St. Rank hold TARA as of Q1 2025.

  • Ikarian Capital reported no remaining Protara Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Ikarian Capital sold 350,489 Protara Therapeutics shares in Q1 2025, an estimated $1.85M.
  • Ikarian Capital first reported a position in Protara Therapeutics in Q4 2019 and held it in 21 quarters.
  • Ikarian Capital's Protara Therapeutics position peaked at $15.7M in Q4 2020.
  • 59 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2025.

Based on Ikarian Capital's 13F filing for Q1 2025, filed 15 May 2025.